Ali S

No ORCID on file · 13 papers in corpus · active 2004-2025

Study types

  • article 3
  • other 2

Condition tags

  • endometriosis 4
  • chronic_pelvic_pain 1
2025
Cureus ·doi:10.7759/cureus.79970

Endometrial adenosarcoma is a rare and aggressive uterine malignancy composed of both epithelial and stromal components, most commonly affecting postmenopausal women. This case report describes the diagnosis of endometrial adenosarcoma in a…

2025
Annals of medicine and surgery (2012) ·doi:10.1097/ms9.0000000000003423

IntroductionArtificial intelligence (AI) is revolutionizing healthcare, particularly in disease diagnostics, by improving accuracy, efficiency, and personalization. Its applications span medical imaging, pathology, and personalized medicine…

2025
Drug design, development and therapy ·doi:10.2147/dddt.s513461

Pyridine carboxylic acid isomers - picolinic acid, nicotinic acid, and isonicotinic acid - have historically resulted in a plethora of drugs against tuberculosis, cancer, diabetes, Alzheimer's, angina, dementia, depression, allergy, respira…

article 2025
Sultan Qaboos University medical journal ·doi:10.18295/2075-0528.2914

Fallopian tube leiomyomas are exceptionally rare parasitic tumours, usually identified incidentally during laparoscopic or open surgery. This report describes a 30-year-old woman who presented in 2025 to Al Emadi Hospital in Doha, Qatar wit…

2024
BMJ open ·doi:10.1136/bmjopen-2024-087431

ObjectivePregnant women with COVID-19 are at elevated risk for severe outcomes, but clinical data on management of these patients are limited. Monoclonal antibodies, such as casirivimab plus imdevimab (CAS+IMD), have proven effective in tre…

other 2024
Antioxidants (Basel, Switzerland) ·doi:10.3390/antiox14010039

Inflammation disrupts the normal function of granulosa cells (GCs), which leads to ovarian dysfunction and fertility decline. Inflammatory conditions such as polycystic ovary syndrome (PCOS), primary ovarian insufficiency (POI), endometrios…

2023
European Journal of Medicinal Chemistry ·doi:10.1016/j.ejmech.2023.115476

The objective of this review is to provide an update on the fluorine-containing drugs approved by U.S. Food and Drug Administration in the span of past five years (2018-2022). The agency accepted a total of fifty-eight fluorinated entities …

2023
Heliyon ·doi:10.1016/j.heliyon.2023.e15166

BackgroundRecurrent miscarriage (RM) represents the spontaneous termination of two or more successive pregnancies. TNFα is a proinflammatory cytokine that is often considered harmful for embryonic development when expressed beyond normal le…

2022
Journal of clinical medicine ·doi:10.3390/jcm11247448

Interleukin-17A (IL17A) is a proinflammatory cytokine and is assumed to play an important role in fetal rejection. In order to evaluate the potential role of IL17A polymorphism in the pathogenesis of recurrent miscarriage (RM), serum IL17A …

article 2015
Journal of cancer science & therapy ·doi:10.4172/1948-5956.1000359

OBJECTIVE: There is an increased risk of developing ovarian cancer (OC) in patients with endometriosis. Hence, development of new biomarkers may provide a positive clinical outcome for early detection. MicroRNAs (miRNAs) are small non-codin…

2015
Journal of cancer science & therapy ·doi:10.4172/1948-5956.1000371

ObjectiveMucinous cystadenocarcinoma of appendix is a rare entity. Differentiating mucinous cystadenocarcinoma from mucinous cystadenoma is very challenging and depends on establishing the presence of malignant cells in the appendix wall. T…

article 2014
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1177/1933719114553064

Endometriosis affects up to 10% of women of reproductive age and 176 million women worldwide. The prevalence in women with infertility is between 30% and 50% but may be higher in women with pelvic pain, interstitial cystitis, or irritable b…

other 2004
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology ·doi:10.1158/1055-9965.2141.13.12

OBJECTIVE: The progestagenic milieu of pregnancy and oral contraceptive use is protective against epithelial ovarian cancer. A functional single nucleotide polymorphism in the promoter of the progesterone receptor (+331A) alters the relativ…